{"DataElement":{"publicId":"5508171","version":"1","preferredName":"Disease or Disorder Status Hematologic Response Level Type","preferredDefinition":"A description of the disease or disorder hematologic response level.","longName":"2512861v1.0:5508136v1.0","context":"NHLBI","contextVersion":"1","DataElementConcept":{"publicId":"2512861","version":"1","preferredName":"Disease or Disorder Status","preferredDefinition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function._A condition or state at a particular time.","longName":"2404658v1.0:2320064v1.0","context":"NHLBI","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2320064","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FC71B93E-037B-5AD9-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-07-25","endDate":null,"createdBy":"REEVESD","dateCreated":"2005-07-25","modifiedBy":"ONEDATA","dateModified":"2005-07-25","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B898979-184A-3A90-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-08-21","endDate":null,"createdBy":"UMLLOADER_AGNIS","dateCreated":"2006-08-21","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"5508136","version":"1","preferredName":"Hematologic Response Level Type","preferredDefinition":"An evaluation of the hematologic response of the disease to the therapy._A position on a scale measuring intensity, quality, or amount._Something distinguishable as an identifiable class based on common qualities.","longName":"5508136v1.0","context":"NHLBI","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"60","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Major cytogenetic response (MCyR)","valueDescription":"Major Cytogenetic Response in Chronic Myelogenous Leukemia, BCR-ABL1 Positive","ValueMeaning":{"publicId":"5524274","version":"1","preferredName":"Major Cytogenetic Response in Chronic Myelogenous Leukemia, BCR-ABL1 Positive","longName":"5524274","preferredDefinition":"A cytogenetic finding indicating Philadelphia chromosome positivity less than or equal to 35% in a patient treated for chronic myelogenous leukemia, BCR-ABL1 positive.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Major Cytogenetic Response in Chronic Myelogenous Leukemia, BCR-ABL1 Positive","conceptCode":"C129529","definition":"A cytogenetic finding indicating Philadelphia chromosome positivity less than or equal to 35% in a patient treated for chronic myelogenous leukemia, BCR-ABL1 positive.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3EE74231-80F7-672E-E053-F662850ADAD1","latestVersionIndicator":"Yes","beginDate":"2016-10-15","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-15","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3F9EFC47-13CF-7075-E053-F662850A15D5","beginDate":"2016-10-24","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-24","modifiedBy":"ONEDATA","dateModified":"2016-10-24","deletedIndicator":"No"},{"value":"Minimal cytogenetic response","valueDescription":"Cytogenetic Minimal Response","ValueMeaning":{"publicId":"5508158","version":"1","preferredName":"Cytogenetic Minimal Response","longName":"5508158","preferredDefinition":"A minimal decrease in abnormal karyotype, based on pre-defined thresholds.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Minimal Response","conceptCode":"C123579","definition":"A minimal decrease in abnormal karyotype, based on pre-defined thresholds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E4A5C62-6655-5C40-E053-F662850A331B","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3E4A5C62-666E-5C40-E053-F662850A331B","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"ONEDATA","dateModified":"2016-10-07","deletedIndicator":"No"},{"value":"Complete molecular remission (CMR)","valueDescription":"Molecular Complete Response","ValueMeaning":{"publicId":"5508160","version":"1","preferredName":"Molecular Complete Response","longName":"5508160","preferredDefinition":"The disappearance of all signs of cancer, supported by molecular analysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Complete Response","conceptCode":"C123593","definition":"The disappearance of all signs of cancer, supported by molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E4A5C62-667B-5C40-E053-F662850A331B","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3E4A5C62-6694-5C40-E053-F662850A331B","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"ONEDATA","dateModified":"2016-10-07","deletedIndicator":"No"},{"value":"Major molecular remission (MMR)","valueDescription":"Molecular Major Response","ValueMeaning":{"publicId":"5508162","version":"1","preferredName":"Molecular Major Response","longName":"5508162","preferredDefinition":"A decrease in signs of cancer, supported by molecular analysis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Molecular Major Response","conceptCode":"C123594","definition":"A decrease in signs of cancer, supported by molecular analysis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E4A5C62-66A1-5C40-E053-F662850A331B","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3E4A5C62-66BA-5C40-E053-F662850A331B","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"ONEDATA","dateModified":"2016-10-07","deletedIndicator":"No"},{"value":"Complete cytogenetic response (CCyR)","valueDescription":"Cytogenetic Complete Response","ValueMeaning":{"publicId":"5508164","version":"1","preferredName":"Cytogenetic Complete Response","longName":"5508164","preferredDefinition":"The disappearance of all signs of cancer, including the absence of a detectable disease-related genetic abnormality, as determined by techniques such as karyotyping or FISH, in response to treatment.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Complete Response","conceptCode":"C123578","definition":"The disappearance of all signs of cancer, including the absence of a detectable disease-related genetic abnormality, as determined by techniques such as karyotyping or FISH, in response to treatment.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E4A5C62-66C7-5C40-E053-F662850A331B","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3E4A5C62-66E0-5C40-E053-F662850A331B","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"ONEDATA","dateModified":"2016-10-07","deletedIndicator":"No"},{"value":"Partial cytogenetic response (PCyR)","valueDescription":"Cytogenetic Partial Response","ValueMeaning":{"publicId":"5508166","version":"1","preferredName":"Cytogenetic Partial Response","longName":"5508166","preferredDefinition":"A partial decrease in abnormal karyotype, based on pre-defined thresholds.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Partial Response","conceptCode":"C123582","definition":"A partial decrease in abnormal karyotype, based on pre-defined thresholds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E4A5C62-66ED-5C40-E053-F662850A331B","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3E4A5C62-6706-5C40-E053-F662850A331B","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"ONEDATA","dateModified":"2016-10-07","deletedIndicator":"No"},{"value":"Minor cytogenetic response","valueDescription":"Cytogenetic Minor Response","ValueMeaning":{"publicId":"5508168","version":"1","preferredName":"Cytogenetic Minor Response","longName":"5508168","preferredDefinition":"A minor decrease in abnormal karyotype, based on pre-defined thresholds.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic Minor Response","conceptCode":"C123580","definition":"A minor decrease in abnormal karyotype, based on pre-defined thresholds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E4A5C62-6713-5C40-E053-F662850A331B","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3E4A5C62-672C-5C40-E053-F662850A331B","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"ONEDATA","dateModified":"2016-10-07","deletedIndicator":"No"},{"value":"No cytogenetic response (No CyR)","valueDescription":"Cytogenetic No Response","ValueMeaning":{"publicId":"5508170","version":"1","preferredName":"Cytogenetic No Response","longName":"5508170","preferredDefinition":"No change in abnormal karyotype, based on pre-defined thresholds.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cytogenetic No Response","conceptCode":"C123581","definition":"No change in abnormal karyotype, based on pre-defined thresholds.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E4A5C62-6739-5C40-E053-F662850A331B","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"3E4A5C62-6752-5C40-E053-F662850A331B","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"ONEDATA","dateModified":"2016-10-07","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"5508135","version":"1","preferredName":"Hematologic Response Level Type","preferredDefinition":"An evaluation of the hematologic response of the disease to the therapy.:A position on a scale measuring intensity, quality, or amount.:Something distinguishable as an identifiable class based on common qualities.","longName":"C123622:C25554:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Hematologic Response","conceptCode":"C123622","definition":"An evaluation of the hematologic response of the disease to the therapy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Level","conceptCode":"C25554","definition":"A position on a scale measuring intensity, quality, or amount.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E4A5C62-6526-5C40-E053-F662850A331B","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"ONEDATA","dateModified":"2016-10-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E4A5C62-6537-5C40-E053-F662850A331B","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"TDIS_CML_dis_stat_resp_level","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLF_DSTE_dis_stat_resp_level","type":"NMDP_FN","context":"NHLBI"},{"name":"CMLP_DSLE_dis_stat_resp_level","type":"NMDP_FN","context":"NHLBI"}],"ReferenceDocuments":[{"name":"What was the disease or disor","type":"Preferred Question Text","description":"What was the disease or disorder hematologic response level?","url":null,"context":"NHLBI"},{"name":"Specify level of response","type":"Application Standard Question Text","description":"Specify level of response","url":null,"context":"NHLBI"},{"name":"Specify level of response","type":"Alternate Question Text","description":"Specify level of response","url":null,"context":"NHLBI"}],"origin":"NMDP:National Marrow Donor Program","workflowStatus":"RELEASED","registrationStatus":"Application","id":"3E4A5C62-677F-5C40-E053-F662850A331B","latestVersionIndicator":"Yes","beginDate":"2016-10-07","endDate":null,"createdBy":"KUMMEROA","dateCreated":"2016-10-07","modifiedBy":"NYCHM","dateModified":"2017-02-02","changeDescription":".","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}